SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-22-006507
Filing Date
2022-05-12
Accepted
2022-05-12 09:41:29
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mnpr_10q.htm   iXBRL 10-Q 601774
2 AMENDED AND RESTATED BYLAWS mnpr_ex31.htm EX-3.1 56163
3 CERTIFICATION mnpr_ex311.htm EX-31.1 12439
4 CERTIFICATION mnpr_ex312.htm EX-31.2 12002
5 CERTIFICATION mnpr_ex321.htm EX-32.1 6676
11 mnpr_10qimg1.jpg GRAPHIC 16772
  Complete submission text file 0001654954-22-006507.txt   3107998

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20220331.xsd EX-101.SCH 35031
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20220331_lab.xml EX-101.LAB 211272
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnpr-20220331_cal.xml EX-101.CAL 28052
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20220331_pre.xml EX-101.PRE 171432
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20220331_def.xml EX-101.DEF 86612
45 EXTRACTED XBRL INSTANCE DOCUMENT mnpr_10q_htm.xml XML 384253
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 22916086
SIC: 2834 Pharmaceutical Preparations